top of page
SPRAVATO® Now at Three Strand Wellness
Spravato is at the forefront of therapies and is being praised for its effectiveness. It regulates feelings of happiness and sadness, and is initially given twice a week for our weeks, then less frequently in maintenance doses.
If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD).
It might be time to talk with us about a different treatment approach. See what makes SPRAVATO® different and learn more about other patients’ experiences with SPRAVATO®.
Adults with treatment-resistant depression who were part of a clinical study were given either a nasal esketamine spray or a placebo spray.
Those who added esketamine, the active ingredient in SPRAVATO®, to their oral antidepressant experienced a greater reduction of depressive symptoms at four weeks compared to those who received placebo plus an oral antidepressant.*
*Based on an overall score on a standardized rating scale.
bottom of page